Results 1 to 3 of 3
Page 1 of 1
TypeTitleAuthor(s)YearViews
Prognostic significance and phenotypic manifestations of MYC/BCL2 protein expression in diffuse large B-cell lymphoma (DLBCL) with extranodal organ involvement: a report of the International DLBCL Rituximab-CHOP Consortium Program StudyMadadi, A; Raghavendra, M; Hu, S; Xu-Monette, ZY; Visco, C; Tzankov, A; Montes-Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Dunphy, CH; Hsi, ED; Zhao, FX; Choi, WWL; Zhao, X; Van Krieken, JHJM; Huh, J; Huang, Q; Ai, W; Ponzoni, M; Ferreri, AJM; Zhou, F; Winter, JN; Piris, M; Møller, MB; Medeiros, LJ; Go, RS; Young, KH201259
 
The t(14;18)(q32;q21) characterizes a subset of patients with diffuse large-B cell lymphoma of germinal center origin with poor outcome: report from the International DLBCL Rituximab-CHOP Consortium Program StudyVisco, C; Tzankov, A; Xu-Monette, ZY; Miranda, RN; d'Amore, ESG; Montes-Moreno, S; Dybkae, K; Chiu, A; Tam, W; Orazi, A; Zu, Y; Bhagat, G; Kahl, BS; Winter, JN; Wang, HY; Dunphy, CH; Hsi, ED; Zhao, FX; Go, RS; Choi, WWL; Zhou, F; Czader, M; Zhao, X; Van Krieken, JHJM; Huang, Q; Ai, W; Etzell, JE; Ponzoni, M; Ferreri, AJM; Piris, MA; Møller, MB; Bueso-Ramos, CE; Medeiros, LJ; Young, KH201173
 
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1Ligtenberg, MJL; Kuiper, RP; Chan, TL; Goossens, M; Hebeda, KM; Voorendt, M; Lee, TYH; Bodmer, D; Hoenselaar, E; HendriksCornelissen, SJB; Tsui, WY; Kong, CK; Brunner, HG; Van Kessel, AG; Yuen, ST; Van Krieken, JHJM; Leung, SY; Hoogerbrugge, N2009105
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download